From the Guidelines
There is no established relationship between Burn Jaro (a GLP-1 receptor agonist) and the development of bud and tree nodules. Burn Jaro appears to be a brand name for a weight loss medication in the GLP-1 receptor agonist class, similar to medications like semaglutide (Wegovy, Ozempic) or liraglutide (Saxenda) 1. These medications work by mimicking the incretin hormone GLP-1, which regulates blood sugar and appetite. They are primarily used for treating type 2 diabetes and obesity. GLP-1 receptor agonists have no known effects on plant development processes like bud formation or tree nodule development. Plant nodule formation, particularly in trees like legumes, is primarily regulated by plant hormones and symbiotic relationships with nitrogen-fixing bacteria, not by mammalian metabolic hormones like GLP-1 1. If you're asking about potential side effects of Burn Jaro that might manifest as nodules in human tissue, there are no specific reports of "bud" or "tree" nodules associated with GLP-1 medications, though injection site reactions can occur with injectable forms of these medications 1. Some common adverse effects of GLP-1 receptor agonists include nausea, vomiting, and diarrhea, which are dose-dependent and more frequent with short-acting drugs 1. However, these side effects do not include the development of bud or tree nodules. The primary benefits of GLP-1 receptor agonists, such as improved glycemic control and weight loss, do not extend to plant development or the formation of nodules on trees. In clinical practice, GLP-1 receptor agonists are used to manage type 2 diabetes and obesity, with a focus on reducing the risk of major adverse cardiovascular events and improving quality of life 1. Therefore, the use of Burn Jaro or other GLP-1 receptor agonists is not associated with the development of bud and tree nodules.